CXCR4 and neoplasm: CXCR4 has been known to be overexpressed in more than 20 human tumor types [13-18], and CXCR4 antagonists inhibit tumor growth in multiple experimental orthotopic [33,34], subcutaneous human xenografts [35,36], and transgenic mouse models [37].